Pharmacyclics got a offer from their partner Johns
Post# of 148187
Quote:
Pharmacyclics got a offer from their partner Johnson & Johnson, yet AbbVie beats that offer significantly, and paid $21 billion only for Pharmacyclics rights.
from wikipedia:
Quote:
Pharmacyclics was acquired by AbbVie in May 2015, and Abbvie projected global sales of US$1 billion in 2016 and $5 billion in 2020
I start to believe we are all too conservative ...
For the takeover concerns:
If I remeber right, CYDY is under Delaware legeslation, and they provide special anti-takeover rights for companys.
Additional, mgmt could just print preferred shares to prevent a takeover offer which is to low.
And than we know Nader would not sell out CYDY without getting the real value.
Maybe it will turn out that Nader was really the best case for our interest and maximum value ...
all imo